Vampires like to bite the necks of victims pumping with blood.
fun fun fun.
With the share price currently sitting at under 30 cents. 25% of the existing shares on issue is what the board is asking shareholders to give them the authority to raise.
That's not a lot of blood/cash.
In my opinion philby, assuming your suggestion of being willing to get onto a plane to visit Singapore and Japan was not bluster and that you had substantial capital at stake as another poster claimed of you and I'd no reason not to believe - I believe you talked a little bit too much nonsense about being a boss of the CEO (without 50% of the voting shares) and about mice cells and elephant cells and growing whiskers and smelling cheese (so didn't look real solid on the science etiher) and failed to think outside the box (like a HNW entrepreur and go getter - you asked how to get John Kings phone number.
Dixon and Forest Capital gave them the the goose that lays many golden eggs.
Did you ever consider talking to Ian Dixon about accompanying you on a plane flight to Sumitomo with a view to seeing if the Sumi offer could be put back on the table for a takeover in 18 months if he was CEO?
Ian seems busy at the moment - but (with respect in contrast to yourself on what I've seen your write and what I've seem him do) he seems to talk quite well in deal making situations based on his past history. But needing some cash. And running a company in takeover mode (as CYP could have been with a new potential CEO running on a promise of a takeover) is different to trying to run it to build it as he currently seems to be doing.
Just my opinion. I mean you no disrespect but I think you deployed the resources that were at you disposal potentially suboptimally so far as I can see.
- Forums
- ASX - By Stock
- Ann: Letter to Shareholders, Notice of AGM & Proxy Form
CYP
cynata therapeutics limited
Add to My Watchlist
9.68%
!
17.0¢

Vampires like to bite the necks of victims pumping with...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
17.0¢ |
Change
0.015(9.68%) |
Mkt cap ! $38.41M |
Open | High | Low | Value | Volume |
15.5¢ | 17.0¢ | 15.5¢ | $47.10K | 289.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 23813 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.165 |
4 | 47240 | 0.155 |
4 | 161673 | 0.150 |
1 | 5000 | 0.145 |
2 | 45000 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 18813 | 2 |
0.175 | 55250 | 1 |
0.180 | 62619 | 3 |
0.185 | 35990 | 1 |
0.195 | 19300 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online